Aesthetic & Dermatology Series

Aesthetic & Dermatology API Projects

PDRN / polynucleotide-related projects, copper peptide complexes, selected cosmetic peptide ingredients, and dermatology-oriented functional ingredient discussions for qualified B2B clients.

Series Overview

Aesthetic & Dermatology Ingredient Projects

Selected peptide and polynucleotide-related ingredient projects may be reviewed for qualified B2B clients, subject to supplier qualification, documentation availability, formulation feasibility, and destination-market requirements.

PDRN & Polynucleotide Projects

Support for qualified B2B projects involving PDRN or polynucleotide-related ingredients, subject to supplier qualification, documentation availability, formulation feasibility, and destination-market requirements.

Copper Peptide Complexes

Copper peptide-related ingredient discussions for qualified aesthetic, dermatology, or formulation-oriented projects, including GHK-Cu and AHK-Cu where applicable.

Cosmetic Peptide Ingredient Portfolio

Selected signal, matrix-support, expression-line, tone, eye-area, hair, and dermatology-oriented peptide ingredient discussions for qualified B2B formulation projects.

Selected Ingredient Portfolio

PDRN / Polynucleotide

PDRNPolynucleotide-related ingredients

Copper Peptides

GHK-CuAHK-Cu

Signal / Matrix-Support Peptides

Palmitoyl Tripeptide-38Palmitoyl Tripeptide-8Matrixyl 3000-type peptide blend projects

Expression-Line Peptides

Acetyl Hexapeptide-8Pentapeptide-18Acetyl Octapeptide-3

Brightening / Even-Tone Peptides

Nonapeptide-1Oligopeptide-68

Eye-Area / Sensitive-Skin Peptides

Acetyl Tetrapeptide-5Acetyl Tetrapeptide-15

Hair & Scalp Peptide Projects

Biotinoyl Tripeptide-1AHK-Cu

Additional Functional Ingredients

Myristoyl Nonapeptide-3Carnosine

Documentation availability depends on supplier, product, batch, and destination market requirements.

Compliance

Availability & Regulatory Notice

Documentation availability depends on supplier, product, batch, and destination market requirements.

Meno Pharma does not claim regulatory approval, registration, or DMF availability for any ingredient unless confirmed in writing with reference to a verified document. Buyers are responsible for independent regulatory due diligence in their market.

Planning an aesthetic or dermatology ingredient project?

Share the ingredient name, target market, required documents, estimated quantity, and intended formulation pathway. Our team will review availability and documentation feasibility.

Request Aesthetic Series Review

For qualified business entities only. All requests are subject to eligibility review, supplier availability, and documentation feasibility.

Qualified business partners

Ready to discuss B2B manufacturing cooperation?

Our team reviews qualified business inquiries within one business day. Please include your company background and product format interest.

Request B2B Quote